Ivoclar Vivadent AG

What does Ivoclar own?

Ivoclar owns dental product lines including IPS e.max ceramics, Bluephase curing lights, Programat furnaces, and digital dentistry systems. It operates 56 subsidiaries worldwide but sells under one master brand.

Is Ivoclar publicly traded?

No. Ivoclar is a private, family-owned company with no stock listing.

Who founded Ivoclar?

Dr. Adolf Schneider founded the company in Zurich in 1923 to manufacture artificial teeth. It has been controlled by the Zeller family for much of its later history.

Where is Ivoclar headquartered?

The company is headquartered in Schaan, Liechtenstein, where it has been based since relocating from Switzerland in 1933.

How many brands does Ivoclar own?

It operates primarily under the single Ivoclar master brand, with product families such as IPS e.max, Bluephase, and Programat rather than a multi-brand portfolio.

Who owns Ivoclar?

The Zeller family owns Ivoclar through family holdings. Christoph Zeller is the principal owner, and the company is family controlled across generations.

What is Ivoclar's revenue?

The company reported 856 million Swiss francs in revenue for fiscal year 2023. It does not release detailed public financial statements beyond headline figures.

The company was founded in 1923 in Zurich, Switzerland, by Dr. Adolf Schneider to manufacture artificial teeth. The artificial tooth business gave the company its original name, derived from ivory-like denture material, and established a dental focus that has never changed.

In 1933 the company relocated to Liechtenstein, where it has remained. It spent the mid-20th century expanding from denture teeth into broader dental materials and equipment, building a reputation in ceramics and restorative systems under successive generations of family ownership through the Zeller family.

The Vivadent name was added in the 1950s, and for decades the company operated as Ivoclar Vivadent. It grew into a global supplier with subsidiaries across Europe, the Americas, and Asia, and invested heavily in R&D at its Schaan headquarters.

In 2022 the company simplified its brand to Ivoclar, dropping Vivadent from its public name while keeping Ivoclar Vivadent AG as the legal entity. A new headquarters building opened in Schaan in 2023 for its centennial. In 2024 it announced a reorganization to cut costs amid currency pressure, affecting about 240 positions worldwide, while continuing investment in digital dentistry and new materials.

Ivoclar reports corporate responsibility efforts focused on manufacturing footprint, training, and education. As a family business it emphasizes long-term stewardship in its public communications, though it does not carry third-party consumer certifications such as B Corp status.

Its ethical posture is shaped by medical device regulation. It operates under ISO standards for dental products and complies with EU MDR and FDA requirements for its materials and equipment, which is the relevant compliance framework rather than consumer goods standards.

Ivoclar has maintained a relatively clean regulatory record typical of a materials supplier. Product issues surface as technical corrections or field notices rather than headline recalls.

The most notable recent scrutiny concerned the 2024 reorganization and roughly 240 job reductions, which drew local attention in Liechtenstein and Austria given the company's role as a major regional employer. The cuts were framed as a response to currency and cost pressure rather than demand collapse.